Group Telehealth Behavioral Cough Suppression Therapy

Description

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Conditions

Refractory Chronic Cough

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Group Telehealth Behavioral Cough Suppression Therapy Pilot Study

Group Telehealth Behavioral Cough Suppression Therapy

Condition
Refractory Chronic Cough
Intervention / Treatment

-

Contacts and Locations

Missoula

University of Montana, Missoula, Montana, United States, 59812

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * At least 18 years old
  • * Predominantly dry cough for at least 8 weeks
  • * Evaluated and treated by at least one physician for cough
  • * Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
  • * Access to a computer or tablet that includes a camera and able to use the device independently
  • * Reliable internet access
  • * Willing to agree to maintain confidentiality of personal information (including names) related to others in the study
  • * Under age 18
  • * Coughing up blood
  • * Current smoker of any substance
  • * History of smoking or 10 or more years
  • * Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma but they have not had any formal lung testing and asthma treatments have not helped your cough, we don't consider this a formal asthma diagnosis and will not exclude them from the study.)
  • * Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).
  • * Complaints of swallowing difficulty
  • * Taking any of the following medications, which have a known side effect of cough: Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)
  • * Prior BCST treatment with an SLP or respiratory therapist

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Montana,

Study Record Dates

2025-01-31